Company Filing History:
Years Active: 2017
Title: Wenxian Cai: Innovator in Pharmaceutical Compounds
Introduction
Wenxian Cai is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical compounds, particularly in the development of innovative drugs related to dopamine and serotonin receptors. His work has implications for treating various diseases associated with these receptors.
Latest Patents
Wenxian Cai holds a patent for a diaryl[A, G]quinolizidine compound, which includes a preparation method, pharmaceutical composition, and its uses. The invention relates to a diarylo[a,g]quinolizidine compound of formula (I), including its enantiomer, diastereoisomer, racemate, mixture, pharmaceutically acceptable salt, crystalline hydrate, or solvate. This compound is significant for preparing experimental model drugs related to dopamine receptors and 5-HT receptors, as well as for developing medicaments aimed at treating or preventing diseases linked to these receptors. He has 1 patent to his name.
Career Highlights
Throughout his career, Wenxian Cai has worked with prominent organizations, including Kingsound & Partner and the Chinese Academy of Sciences. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Wenxian Cai has collaborated with notable colleagues such as Hong Tao Liu and Xuechu Zhen. These partnerships have enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Wenxian Cai is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of diseases related to dopamine and serotonin receptors. His innovative contributions continue to advance the field of medicine.